Eikon Therapeutics, Inc.
EIKN
$8.88
-$0.10-1.11%
NASDAQ
| 03/31/2026 | 12/31/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Net Income | -82.96M | -79.66M | -68.24M | ||
| Total Depreciation and Amortization | 5.11M | 5.11M | 6.47M | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 1.95M | 3.21M | 1.74M | ||
| Change in Net Operating Assets | -13.91M | 29.62M | 5.52M | ||
| Cash from Operations | -89.80M | -41.72M | -54.52M | ||
| Capital Expenditure | -262.00K | -66.00K | -22.36M | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -202.96M | 40.78M | -191.50M | ||
| Cash from Investing | -203.22M | 40.71M | -213.85M | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 349.31M | 1.09M | 21.00K | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | 0.00 | 350.21M | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | 349.31M | 1.09M | 350.23M | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 56.29M | 75.00K | 81.86M | ||